China Universal Asset Management Company’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
Other funds holding MRVI
DRP
SO
PFSRSONJ
S
AHL
EI
SI
FFA
China Universal Asset Management Company's MRVI Position: Q2 2026 in Review
China Universal Asset Management Company reduced its Maravai LifeSciences (MRVI) stake by 9.6% in Q2 2026, selling an estimated $10.8K and leaving 23,476 shares worth $146K. The position accounts for 0.01% of the portfolio, ranked #381.
China Universal Asset Management Company first reported a position in MRVI in Q3 2022 and has held it in 16 quarters since. The position peaked at $226K in Q3 2024. 20 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.
- China Universal Asset Management Company held 23,476 shares of Maravai LifeSciences worth $146K as of Q2 2026.
- China Universal Asset Management Company sold 2,501 Maravai LifeSciences shares in Q2 2026, an estimated $10.8K.
- Maravai LifeSciences made up 0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #381 holding.
- China Universal Asset Management Company first reported a position in Maravai LifeSciences in Q3 2022 and has held it in 16 quarters since.
- China Universal Asset Management Company's Maravai LifeSciences position peaked at $226K in Q3 2024.
- 20 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.
Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.